These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36646212)
1. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives. Fragkou PC; Moschopoulos CD; Dimopoulou D; Triantafyllidi H; Birmpa D; Benas D; Tsiodras S; Kavatha D; Antoniadou A; Papadopoulos A Hellenic J Cardiol; 2023; 71():42-54. PubMed ID: 36646212 [TBL] [Abstract][Full Text] [Related]
2. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Losina E; Hyle EP; Borre ED; Linas BP; Sax PE; Weinstein MC; Rusu C; Ciaranello AL; Walensky RP; Freedberg KA Clin Infect Dis; 2017 Oct; 65(8):1266-1271. PubMed ID: 28605504 [TBL] [Abstract][Full Text] [Related]
3. Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study. Kapelios CJ; Argyris AA; Protogerou AD; Katsarolis I; Arida A; Papadopoulou M; Ntaroutsou E; Kitas G; Sfikakis PP; Psichogiou M J Acquir Immune Defic Syndr; 2020 Apr; 83(5):504-512. PubMed ID: 31923089 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in HIV patients: recent advances in predicting and managing risk. McGettrick P; Mallon PWG; Sabin CA Expert Rev Anti Infect Ther; 2020 Jul; 18(7):677-688. PubMed ID: 32306781 [TBL] [Abstract][Full Text] [Related]
5. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations. Achhra AC; Lyass A; Borowsky L; Bogorodskaya M; Plutzky J; Massaro JM; D'Agostino RB; Triant VA Curr HIV/AIDS Rep; 2021 Aug; 18(4):271-279. PubMed ID: 34247329 [TBL] [Abstract][Full Text] [Related]
6. The pharmacological management of cardiovascular disease in people living with HIV (PLWH). Corbacho N; Mur I; Molas ME; Vidal F; Domingo P Expert Opin Pharmacother; 2021 Apr; 22(6):743-753. PubMed ID: 33283570 [TBL] [Abstract][Full Text] [Related]
7. HIV and Global Cardiovascular Health. Wagle A; Goerlich E; Post WS; Woldu B; Wu KC; Hays AG Curr Cardiol Rep; 2022 Sep; 24(9):1149-1157. PubMed ID: 35802233 [TBL] [Abstract][Full Text] [Related]
8. Managing cardiovascular risk in people living with HIV in Asia - where are we now? Choi JY; Lui GCY; Liao CT; Yang CJ HIV Med; 2022 Feb; 23(2):111-120. PubMed ID: 34494350 [TBL] [Abstract][Full Text] [Related]
9. Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis. Zhu S; Wang W; He J; Duan W; Ma X; Guan H; Wu Y; Li S; Li Y; Tian T; Kong W; Wu D; Zhang T; Huang X J Glob Health; 2024 Apr; 14():04078. PubMed ID: 38666515 [TBL] [Abstract][Full Text] [Related]
10. Imaging modalities for cardiovascular phenotyping in asymptomatic people living with HIV. Bonou M; Kapelios CJ; Athanasiadi E; Mavrogeni SI; Psichogiou M; Barbetseas J Vasc Med; 2021 Jun; 26(3):326-337. PubMed ID: 33475050 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting statin uptake among people living with HIV: primary care provider perspectives. Ober AJ; Takada S; Zajdman D; Todd I; Horwich T; Anderson A; Wali S; Ladapo JA BMC Fam Pract; 2021 Oct; 22(1):215. PubMed ID: 34717560 [TBL] [Abstract][Full Text] [Related]
12. The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review. Kelso NE; Sheps DS; Cook RL Am J Drug Alcohol Abuse; 2015; 41(6):479-88. PubMed ID: 26286352 [TBL] [Abstract][Full Text] [Related]
13. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy. Jaworowski A; Hearps AC; Angelovich TA; Hoy JF Front Immunol; 2019; 10():1378. PubMed ID: 31275317 [TBL] [Abstract][Full Text] [Related]
14. Physical activity and exercise to improve cardiovascular health for adults living with HIV. Ozemek C; Erlandson KM; Jankowski CM Prog Cardiovasc Dis; 2020; 63(2):178-183. PubMed ID: 32014512 [TBL] [Abstract][Full Text] [Related]
15. Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa. Okello S; Amir A; Bloomfield GS; Kentoffio K; Lugobe HM; Reynolds Z; Magodoro IM; North CM; Okello E; Peck R; Siedner MJ Prog Cardiovasc Dis; 2020; 63(2):149-159. PubMed ID: 32035126 [TBL] [Abstract][Full Text] [Related]
16. Exercise to Prevent Accelerated Vascular Aging in People Living With HIV. Jones R; Robinson AT; Beach LB; Lindsey ML; Kirabo A; Hinton A; Erlandson KM; Jenkins NDM Circ Res; 2024 May; 134(11):1607-1635. PubMed ID: 38781293 [TBL] [Abstract][Full Text] [Related]
17. Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort. Safo SE; Haine L; Baker J; Reilly C; Duprez D; Neaton JD; Jain MK; Arenas-Pinto A; Polizzotto M; Staub T; J Am Heart Assoc; 2023 Jul; 12(13):e027273. PubMed ID: 37345752 [TBL] [Abstract][Full Text] [Related]
18. Burden of subclinical carotid atherosclerosis and vascular risk factors among people living with HIV in Ghana. Sarfo FS; Nichols M; Agyei B; Singh A; Ennin E; Nyantakyi AD; Asibey SO; Tagge R; Gebregziabher M; Jenkins C; Ovbiagele B J Neurol Sci; 2019 Feb; 397():103-111. PubMed ID: 30599299 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya. Temu TM; Kirui N; Wanjalla C; Ndungu AM; Kamano JH; Inui TS; Bloomfield GS BMC Infect Dis; 2015 Oct; 15():421. PubMed ID: 26466584 [TBL] [Abstract][Full Text] [Related]
20. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. Hyle EP; Mayosi BM; Middelkoop K; Mosepele M; Martey EB; Walensky RP; Bekker LG; Triant VA BMC Public Health; 2017 Dec; 17(1):954. PubMed ID: 29246206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]